The first such drug to be approved by the FDA is an anticoagulant called antithrombin, and it is secreted in the milk of genetically modified goats. Another approved drug is isolated from the milk of transgenic rabbits, and in 2015, the FDA gave the go-ahead for a protein-based drug that is purified from the egg whites of transgenic chickens.
